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Abstract
Aim: To present a visual representation of changes in body composition, leptin, insulin, estradiol and
follicular stimulating hormone (FSH) levels in relation to menarche in girls.
Methods: Participants were a subset of healthy girls (n = 108) enrolled in a longitudinal study of
growth and development conducted at the General Clinical Research Center at the Massachusetts
Institute of Technology (MIT). Participants were seen annually from before menarche until 4 years
postmenarche for measures of body composition and serum levels of leptin, insulin, estradiol and
FSH. Body composition was determined by bioelectrical impedance. Standardized body composition
and hormone levels were smoothed and plotted relative to menarche to visualize patterns of change.
Results: At menarche, the mean percentage body fat (%BF) of girls was 24.6% (SD = 4.1%) after
menarche %BF was ∼27%. Leptin levels averaged 8.4 ng/mL (SD = 4.6) at menarche and were
∼12 ng/mL after menarche. Changes in leptin levels closely paralleled changes in %BF. Insulin,
estradiol and FSH levels followed expected patterns relative to menarche. Leptin began rising closer
to menarche than did insulin or the other sex hormones.
Conclusion: We provide a visual presentation of hormonal and body composition changes occurring throughout
the pubertal period in girls which may be useful in generating new hypotheses related to the timing of menarche.
The time between childhood and adolescence in girls is char-
acterized by dynamic changes in body composition and the
hormonal milieu. Although pubertal transitions begin years
before the onset of menarche and continue for several years
afterwards, menarche is a definable event that provides a
subject-specific time point to which changes occurring over
the pubertal period can be compared.
Many studies have examined inter-relationships between
hormones and body composition during puberty in girls
(1,2). Although the role of the adipocyte hormone, leptin,
discovered in 1994 (3) has begun to be incorporated into
our understanding of puberty (4–10), the inter-relationships
of leptin, insulin, the sex hormones and body composi-
tion relative to age at menarche have not been thoroughly
examined.
In this study we followed a cohort of healthy girls from
several years before menarche until 4 years after menarche.
This study builds on work by others (2,5,7,8) by including
leptin, sex hormones, insulin and body composition in anal-
yses and providing a visual representation that allows for
comparison of patterns relative to menarche.
METHODS
Study participants
Participants in this study, initiated in 1993, were part of a
larger cohort of girls enrolled in the Massachusetts Institute
of Technology (MIT) Growth and Development study (11)
conducted at the MIT Clinical Research Center. The crite-
ria for enrollment were premenarcheal status and a triceps
skinfold less than the 85th percentile for age and sex (12).
Participants (n = 196) aged 8–12 years (mean = 10 years)
were enrolled between 1990 and 1993, having been re-
cruited from the Cambridge and Somerville public schools in
Massachusetts, the MIT summer day camp and friends and
siblings of enrolled subjects. All participants were healthy;
and at study entry were not taking anymedication that might
affect body composition or energy expenditure. Participants
included in this analysis (n = 108) were older at menarche
than the girls in the larger cohort (13.2 years vs. 12.9 years)
because the laboratory assays were added in year 3 of study
entry and participants had to have at least one blood sam-
ple available for hormonal analysis. The study protocol was
approved by both the Committee on the Use of Humans as
Experimental Subjects at MIT and the Human Investigation
Review Committee of the New England Medical Center.
Subjects enrolled in the MIT growth and development
study were followed annually until 4 years after menarche.
At each visit, they were examined by a physician to insure
that they were in good health. Menarche was determined
prospectively. Participants were asked to phone when they
got their first period, and they also were asked at each an-
nual visit if they had reached menarche. Body composition
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at baseline and at each follow-up visit was measured by bio-
electrical impedance and percentage body fat (%BF) was
estimated using cohort-specific equations validated within
the cohort against measures of total body water, as previ-
ously described (13).
Serum hormone levels
Participants were asked to provide a blood sample for analy-
sis of leptin, insulin, estradiol and follicular stimulating hor-
mone (FSH) at each visit. Blood samples were drawn before
9 a.m. and after a 10- to 12-h fast. For subjects who had
reached menarche, blood was drawn 5–10 days after the
start of menses. When a subject’s visit did not fall within
the day 5- to day 10-window relative to her menstrual pe-
riod, she was invited to return during the appropriate time
in her cycle in the subsequent months to provide an addi-
tional blood sample for determination of sex hormone levels.
Our analyses included measurements of insulin and leptin,
but not of FSH or estradiol for blood samples obtained out-
side of the 5–10 day window of the follicular phase. With
the exception of insulin, we excluded from analyses hor-
mone data for any participants taking oral contraceptives at
the time of the visit.
Hormone assays
Serum samples were stored at−80◦C before analyses. Serum
samples were analyzed for leptin, insulin, estradiol and FSH
by radio-immunoassay. The set of samples for each subject
were run together when possible. Additional samples ob-
tained in later years were run within a year of blood draw
and were not run with the subject’s original set. Plasma in-
sulin and leptin were analyzed by a double antibody ra-
dioimmunoassay (LINCO RIA Laboratories, St. Charles,
MO). Insulin and leptin inter-assay coefficients of variation
were 9.3% and 8.7% and the intra-assay coefficients of vari-
ation were 4.5% and 6.5%. Estradiol was measured using
a radioimmunoassay from Diagnostic System Laboratory
(DSL). The inter- and intra-assay coefficients of variation
were respectively, 9.3% and 5.3%. FSH was measured by
an immunoradiometric assay (IRMA). The intra-assay coef-
ficient of variation for FSH was 6.2%.
Analysis
Means and standard deviations of hormone and body com-
position variables were calculated by maturational status
categories that were defined as: between 3 years and 1 year
before menarche, between 1 year before and 1 year after
menarche (the menarcheal interval), between 1 year and
3 years after menarche, and 3 or more years after menarche.
Generalized additive modeling (GAM) was used to visualize
the smoothed relationship between leptin and percentage
body fat, total body fat, and fat-free mass relative to menar-
che. We also used GAM to visualize the relationship of lep-
tin, FSH, insulin and estradiol relative to menarche (14).
We applied internally referenced z-score transformations to
hormone and body composition values to allow for compari-
son among variables measured in different scales, to observe
patterns relative to menarche. Finally, to establish the trend
in these variables while accounting for repeated measure-
ments on the same individuals, we used linear mixed effects
models. In these models, the slope represents the annual rate
of change in the z-score modeled over time, with time de-
fined relative to each participant’s menarche. The intercept
reflects the level of each variable, expressed as a z-score, at
menarche.
RESULTS
Data from 108 participants were included in this analysis. Of
these, 78% were white, 13% were African American and 9%
were of other race/ethnicities. Average (SD) age at menar-
che of participants was 13.19 (1.58) years. These 108 par-
ticipants provided 377 measurements of body composition
and hormone levels across a period ranging from 4.5 years
before menarche to 4.3 years after menarche as part of a
longitudinal study of the relationship of energy expenditure
to weight gain during adolescence (15). Subjects in this anal-
ysis provided a mean (SD) of 3.5 (1.9) measurements each,
with 63% of subjects contributing three or more repeated
measures. The maximum number of measurements provided
by a participant was nine, 14% of participants provided
one measurement and 17% provided six or more repeated
measures.
Table 1 provides means and standard deviations for hor-
mone and body composition measures, in the units in which
they were measured, by maturational status category. At the
menarcheal interval participants weighed on average 48 kg,
of which 36 kg was fat-free mass (FFM) and 12 kg was fat
mass (25% body fat). Leptin levels were 8.4 ng/mL.
Figure 1 shows body composition and serum leptin levels
relative to menarche. These points represent averaged and
smoothed data fromGAMmodels that included all available
Table 1 Body composition and serum hormone levels relative to menarche
Maturational stage
3 years to Within 1 year 1 year to >3 years
1 year before of menarche 3 years after after
menarche menarche menarche
n 61 97 56 57
Age (years) 12.0 (1.0) 13.6 (1.1) 15.5 (1.3) 17.2 (1.1)
Weight (kg) 39.7 (6.3) 48.0 (6.4) 56.2 (6.2) 59.2 (6.9)
Fat-free mass (kg) 29.7 (3.5) 36.1 (4.0) 40.9 (3.6) 42.9 (4.1)
Fat (kg) 10.1 (3.9) 12.0 (3.2) 15.4 (3.5) 16.3 (3.6)
Percentage body fat 24.8 (5.8) 24.6 (4.1) 27.1 (3.9) 27.3 (3.5)
Leptin (ng/mL) 7.1 (5.5) 8.4 (4.6) 12.5 (6.7) 12.2 (6.1)
Insulin (μU/mL) 12.3 (5.6) 14.4 (6.9) 13.3 (7.7) 11.4 (5.2)
FSH (mIU/mL) 2.5 (1.4) 3.9 (1.6) 2.8 (1.0) 2.7 (1.7)
Estradiol (pg/mL) 20.3 (13.3) 36.6 (19.6) 46.5 (34.4) 50.9 (47.5)
Data represent means (standard deviations). If a subject had more than one
observation within a maturational stage, only one observation was included in
this table. Decisions were as follows: for all categories except >3 years after
menarche, the assessment at which the subject’s age relative to menarche
was closest to the middle of the maturational stage was chosen, and for the
category of >3 years after menarche the latest assessment (when subject was
oldest) was chosen to maximize range.
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Figure 1 Body composition changes and serum leptin levels relative to menarche. Standard deviation score transformations were applied based on FFM (mean =
36.44, SD = 6.38 kg), Fat (mean = 12.95, SD = 4.20 kg), leptin (mean = 9.48, SD = 5.86 ng/mL) and %BF (mean = 25.75, SD = 4.46).
Figure 2 Change in serum hormone levels relative to menarche in years. Standard deviation score transformations were applied based on FSH (mean = 3.11, SD =
1.64 mIU/mL), insulin (mean = 13.17, SD = 6.51 μU/mL), estradiol (mean = 46.12, SD = 36.41 pg/mL) and leptin (mean = 9.48, SD = 5.86 ng/mL).
observations. As can be seen in Figure 1, the change in slope
that occurs around menarche for leptin parallels changes
that occur in percentage body fat. FFM and total body fat
are higher at later maturational ages, reflecting growth and
the accretion of both lean and fat tissue over the pubertal
period.
Figure 2 shows standardized levels of the hormones, FSH,
insulin, estradiol and leptin plotted relative to menarche
from GAM models. The relationship between leptin lev-
els and FSH, insulin and estradiol in girls at menarche
has not been well understood. This figure allowed us to
examine relationships between changing levels of insulin,
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Table 2 Results of linear mixed effects models predicting body composition and
hormone levels (as z-scores) over time expressed as age relative to menarche
Intercept Slope (p-value)
Fat mass −0.138 0.254 (0.0001)
Fat-free mass −0.199 0.363 (0.0001)
Percentage body fat −0.055 −0.090 (0.0001)
Leptin −0.050 0.147 (0.0001)
Insulin −0.005 0.003 (0.89)
FSH 0.041 0.034 (0.22)
Estradiol −0.058 0.146 (0.0001)
FSH and estradiol in association with leptin. To increase
interpretability, we describe these patterns relative to mat-
uration from 2 years before menarche to 4 years after
menarche, acknowledging that these figures are a combina-
tion of cross-sectional information and prospective informa-
tion. FSH rose in the premenarcheal period, peaked about
6 months before menarche, and then declined to a plateau
approximately 2 years after menarche. Insulin also peaked
about 6 months before menarche and then declined to
prepubertal levels, consistent with the insulin resistance as-
sociated with puberty (16). Estradiol rose steadily before
menarche and did not decline until 2–3 years after menar-
che. In contrast, leptin levels began to increase just prior
to menarche, later than estradiol, FSH and insulin. Unlike
insulin and FSH, leptin levels did not peak but rather rose
until 2 years after menarche and then leveled off. All other
hormone levels appeared to stabilize around 2 years after
menarche with only insulin returning to prepubertal levels.
Results of linear mixed effects modeling to assess the
presence of a linear change in body composition and hor-
mone levels expressed as z-scores over time are presented in
Table 2. The intercept represents the mean value in z-score
units at the time of menarche. The slope represents the
mean annual change in z-score units. As expected based
on the visual representation, significant increases with age
relative to menarche are seen for percent body fat, fat-free
mass, fat mass, leptin and estradiol, but not for insulin and
FSH.
DISCUSSION
Our analysis of data collected from a cohort of girls who
were followed from before menarche until 4 years after
menarche offers a visualization of the interrelationships
between changes in body composition and changes in
leptin, estradiol, FSH and insulin, during the pubertal
transition. Several studies have examined the relationship
between leptin and body composition over the pubertal pe-
riod (4,6,8,17), and two have investigated the relationship
between sex hormones and body composition during pu-
berty (1,2). Only a few have examined both leptin and sex
hormones in relation to body composition at this time (5,7).
Adding to that knowledge, we have presented hormone lev-
els and body composition in relation to menarche, and thus
have standardized them to a biological time point. Hor-
monal and body composition changes during the pubertal
period are best studied in relation to age at menarche rather
than chronological age because of the large variability in
maturational development among girls who are the same
chronological age (18).
Our observations are consistent with those of others. As
would be expected insulin, FSH and estradiol rose well be-
fore menarche (16,18). Our findings of an increase in FSH
and estradiol 2 years before menarche are in agreement with
those of Legro et al. (2). We observed a decrease in FSH lev-
els around the time of menarche and a leveling off of estra-
diol 2 years after menarche. Body composition and serum
leptin levels at menarche were similar to those reported by
Matkovic (8).
As has been found in other studies (4,6,8,17), we observed
a very close association between relative body fatness and
serum leptin levels as girls matured. Until about 3–6 months
before menarche, mean percentage body fat in these girls
was unchanged. Likewise until shortly before menarche,
serum leptin levels were stable or only slightly increasing.
The increase in slope of percentage body fat that occurred
in the 6 month period before menarche coincided with an
increase in slope of serum leptin levels, and when percent-
age body fat began to plateau a year or so after menarche,
serum leptin levels also stabilized. Our data provide further
evidence that changes in leptin levels reflect changes in body
fatness across puberty in girls. We acknowledge, however,
that we used an indirect measure of body composition, bio-
electrical impedance, to estimate body fatness. We were able
to use a cohort-specific equation developed from multiple
measures of total body water at different time points. In or-
der to calculate body fat from this measure, an assumption
is made that the hydration of FFM is constant. Individual
variability in the hydration constant could introduce some
error in the measurement of FFM and percent body fat.
Our ability to draw conclusions about the dynamics of
leptin changes more than 2 years before menarche is lim-
ited by having fewer observations from this maturational
period. This is to be expected because premenarcheal girls
between ages 8 and 12 years (mean 10.1 years) were enrolled
in the study and at enrollment their age at menarche was
unknown. In addition blood collection did not begin until
1993. Therefore when our observations are arrayed relative
to age at menarche, as in the figures and GAM analyses that
generated them, fewer observations are available from the
early pubertal period.
Frisch suggested years ago that menarche required
sufficient body fat stores to support reproduction (19). De-
spite considerable research, this hypothesis remains con-
troversial, in part, because of the lack of a molecular
mechanism to signal that fat stores are adequate for re-
production. The discovery of leptin (3) led to speculation
that it might represent that molecular signal. Matkovic
et al. (8) studied pubertal girls for 4 years and investi-
gated associations between leptin levels and age at menar-
che in relation to body composition. They concluded that
for menarche to occur, leptin levels must reach a criti-
cal level. Although it is possible that a sufficient level of
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leptin is required to initiate menarche, our data do not
support the notion that leptin rises sharply prior to menar-
che. Because changes in leptin parallel changes in body fat-
ness, it remains uncertain whether leptin is the signal. The
observation that leptin more closely tracks percentage body
fat than fat mass beyond 2 years after menarche suggests
that relative fatness may be more important than absolute
body fat in body weight regulation and reproduction.
The strengths of our study include the prospective assess-
ment of menarche, repeated measurements over the puber-
tal period, and concurrent measures of body composition
and hormone levels. However, our study, like several oth-
ers (7,8), is limited by the number and timing of samples.
In theory, patterns of change in hormone levels and body
composition relative to menarche in girls could be studied in
cross-sectional or prospective study designs, with different
strengths and limitations of each approach.
Advantages of cross-sectional studies, such as reported
by Horlick (5), Ellis (17) and Arslanian (4) include ensur-
ing consistency of methodology across measurements, speed
and logistics. Disadvantages to this approach are that mea-
surements cannot be ordered relative to age at menarche,
because the time to menarche for premenarcheal girls is
unknown, and for girls who are postmenarcheal their re-
called age at menarche must be used and reliance on mem-
ory would be expected to introduce some misclassification
error (20). In addition, an important assumption underly-
ing interpretation of hormone levels and body composi-
tion patterns relative to pubertal development in a study
with a single measurement occasion is that the main differ-
ence between subjects is in sexual development. However,
race/ethnicity, body type, or athleticism might also be asso-
ciated with hormone levels and body composition. Thus, it
is difficult to know whether differences in hormone levels
or body composition across maturational stage observed in
a cross-sectional study are due to maturation or to who was
measured.
Optimally, a prospective study design would include
closely spaced measurements of hormone levels and body
composition in a large group of young girls followed for
many years. This design would provide individual trajecto-
ries of change in hormone levels and body composition for
each girl, and one could average these trajectories to es-
timate the pattern of change in hormone levels and body
composition relative to age at menarche. The advantage of
this type of study design would be direct measurement of
change within individuals; however the difficulties in con-
ducting such a study would be great in terms of time, cost,
subject burden and logistics. Ahmed et al. (6) and Matkovic
et al. (8) studied girls measured repeatedly during puberty;
however, their analytic approach resulted in linear models
of association. For non-linear trajectories to be estimated,
individual observations would need to be closely spaced in
time.
The analyses presented in our report, and those by
Demerath (7) represent a combination of cross-sectional
and prospective designs. The participants in our study were
followed over time, and age at menarche was determined
prospectively, but participants varied in their number and
spacing of measurements. The visualization of the interrela-
tionships of hormone levels and body composition relative
to age at menarche that we provide in the figures, using a
GAM approach, allows for inclusion of all available mea-
surements. Forty-five percent of subjects were measured on
four or more occasions, 63% were measured on three or
more occasions and 6% were measured on seven or more
occasions. However, 14% of subjects were measured on only
one occasion. With this number and variability in measure-
ments, one can only fit a straight line. However, it is evident
that much information is lost with this approach. For rea-
sons of practicality, it was difficult to obtain repeated mea-
sures of sex hormone levels on the entire sample because
the measurements need to be done during a small window
of time relative to the menstrual cycle. Although only ap-
proximately half of the girls in the cohort elected to partic-
ipate, reasons for non-participation are unlikely to bias our
results.
In conclusion, this visual presentation of the hormonal
and body composition changes occurring throughout the
pubertal period in girls may be useful in generating new
hypotheses related to the timing of menarche.
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